Perhaps the most widely discussed EXCURSIONS-related problem was the argument over the impact of the agreement on efforts to enhance public health in the developing world.
Some developing countries maintained that TRIPS patent rules prevented them from having access to essential medications, concerns that were intensified by the dramatic rise in the incidence of HIV/AIDS. Nonprofits such as Doctors without Borders accuse drug company of putting "patents over individuals." Dialogues ensued at the WTO to address these concerns. HKS Case Number 1736.3
PUBLICATION DATE: March 24, 2008 PRODUCT #: 108069-HCB-ENG
Transparent Value LLC Case Study Solution
This is just an excerpt. This case is about FINANCE & ACCOUNTING